10x Genomics (TXG) Other Working Capital Changes (2018 - 2026)

10x Genomics has reported Other Working Capital Changes for 9 years, with the latest figure at -$50000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 91.3% year-over-year to -$50000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 138.84% YoY) and the FY2025 annual result came in at -$1.8 million, down 325.9% from the prior year.
• Other Working Capital Changes eased to -$50000.0 in Q1 2026 per TXG's latest filing, from $5.8 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $10.5 million in Q1 2023 and troughed at -$8.3 million in Q2 2023.
• A 5-year average of $230176.5 and a median of $149000.0 in 2025 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes sank 2791.84% in 2024, then surged 4390.0% in 2025.
• Over 5 years, Other Working Capital Changes stood at $6.5 million in 2022, then tumbled by 143.03% to -$2.8 million in 2023, then jumped by 104.63% to $130000.0 in 2024, then soared by 4390.0% to $5.8 million in 2025, then sank by 100.86% to -$50000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$50000.0, $5.8 million, and -$8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.